Apellis Pharmaceuticals (APLS) Leases: 2020-2025
Historic Leases for Apellis Pharmaceuticals (APLS) over the last 6 years, with Sep 2025 value amounting to $19.7 million.
- Apellis Pharmaceuticals' Leases rose 15.59% to $19.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $19.7 million, marking a year-over-year increase of 15.59%. This contributed to the annual value of $16.1 million for FY2024, which is 3.95% down from last year.
- As of Q3 2025, Apellis Pharmaceuticals' Leases stood at $19.7 million, which was up 34.73% from $14.6 million recorded in Q2 2025.
- In the past 5 years, Apellis Pharmaceuticals' Leases registered a high of $22.5 million during Q1 2021, and its lowest value of $14.6 million during Q2 2025.
- In the last 3 years, Apellis Pharmaceuticals' Leases had a median value of $16.3 million in 2024 and averaged $16.4 million.
- Per our database at Business Quant, Apellis Pharmaceuticals' Leases soared by 69.30% in 2021 and then decreased by 20.68% in 2023.
- Over the past 5 years, Apellis Pharmaceuticals' Leases (Quarterly) stood at $19.9 million in 2021, then fell by 5.80% to $18.7 million in 2022, then declined by 10.68% to $16.7 million in 2023, then declined by 3.95% to $16.1 million in 2024, then climbed by 15.59% to $19.7 million in 2025.
- Its Leases was $19.7 million in Q3 2025, compared to $14.6 million in Q2 2025 and $15.3 million in Q1 2025.